BranTussin DM
- Product NDC
- 71321-700
- Requested package NDC
- 71321-700-16
- 11-digit product format
- 713210700
- Labeler code
- 71321
- Product ID
- 71321-700_eaf11cdf-197e-b595-e053-2995a90a3784
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Dexbrompheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Brandywine Pharmaceuticals, LLC
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-10-14
- Marketing end
- 0000-00-00
- Substance
- DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 2 mg/5mL; mg/5mL; mg/5mL
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71321-700 | BRANTUSSIN DM (DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL) LIQUID [BRANDYWINE PHARMACEUTICALS, LLC] | 2 | Legacy NDC | 20240110_eaf11ba7-b0e2-a422-e053-2995a90ae2a9.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71321-700-16 | 71321070016 | 473 mL in 1 BOTTLE (71321-700-16) | 473 ml | 2022-10-14 | 0000-00-00 | No | No | Current |